pharmaceutical composition comprising a sglt2 inhibitor, a dpp-iv inhibitor and optionally another antidiabetic agent and uses thereof, as well as a kit comprising them
Leo John Seman,Leo Thomas,Michael Mark,Peter Eickelmann,Rolf Grempler,Uli Broedl
申请号：
BRPI1008560
公开号：
BRPI1008560A2
申请日:
2010.02.11
申请国别(地区):
BR
年份:
2020
代理人:
摘要：
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
